Literature DB >> 17785800

A key role for TGF-beta signaling to T cells in the long-term acceptance of allografts.

Stephen R Daley1, Jianbo Ma, Elizabeth Adams, Stephen P Cobbold, Herman Waldmann.   

Abstract

TGF-beta is a key immunoregulatory cytokine which supports self-tolerance by signaling to T cells. In this report, we show a crucial role for TGF-beta signaling to T cells in enabling the long-term acceptance of allografts, whether natural or induced therapeutically by coreceptor and costimulation blockade. The requirement for TGF-beta appears most pronounced during the initial exposure to alloantigens. We demonstrate the ability of TGF-beta to direct the development in vitro of regulatory cells that suppress graft rejection in vivo. Such suppression was not affected by anti-TGF-beta treatment of the recipient mice. Despite this, TGF-beta may still have a role in CD4+ cell-mediated suppression of antiallograft responses in vivo, since its neutralization can, in some cases, abrogate suppression. These results show that TGF-beta signaling to T cells is dispensable for mounting destructive responses against skin allografts while appearing to be an essential intermediary in establishing long-term tolerance.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17785800     DOI: 10.4049/jimmunol.179.6.3648

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  27 in total

1.  T regulatory cells participate in the control of germinal centre reactions.

Authors:  Carla-Maria Alexander; Lorraine T Tygrett; Alexander W Boyden; Kristy L Wolniak; Kevin L Legge; Thomas J Waldschmidt
Journal:  Immunology       Date:  2011-06-03       Impact factor: 7.397

Review 2.  The challenge of immunogenicity in the quest for induced pluripotency.

Authors:  Paul J Fairchild
Journal:  Nat Rev Immunol       Date:  2010-12       Impact factor: 53.106

Review 3.  The role of lymphocytes in the development and treatment of alopecia areata.

Authors:  Hongwei Guo; Yabin Cheng; Jerry Shapiro; Kevin McElwee
Journal:  Expert Rev Clin Immunol       Date:  2015-09-07       Impact factor: 4.473

4.  Spontaneous renal allograft acceptance associated with "regulatory" dendritic cells and IDO.

Authors:  Charles H Cook; Alice A Bickerstaff; Jiao-Jing Wang; Tibor Nadasdy; Patricia Della Pelle; Robert B Colvin; Charles G Orosz
Journal:  J Immunol       Date:  2008-03-01       Impact factor: 5.422

5.  Regulation and privilege in transplantation tolerance.

Authors:  Herman Waldmann; Elizabeth Adams; Paul Fairchild; Stephen Cobbold
Journal:  J Clin Immunol       Date:  2008-09-06       Impact factor: 8.317

6.  Infectious tolerance via the consumption of essential amino acids and mTOR signaling.

Authors:  Stephen P Cobbold; Elizabeth Adams; Claire A Farquhar; Kathleen F Nolan; Duncan Howie; Kathy O Lui; Paul J Fairchild; Andrew L Mellor; David Ron; Herman Waldmann
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-30       Impact factor: 11.205

7.  Rapamycin-conditioned donor dendritic cells differentiate CD4CD25Foxp3 T cells in vitro with TGF-beta1 for islet transplantation.

Authors:  K L Pothoven; T Kheradmand; Q Yang; J L Houlihan; H Zhang; M Degutes; S D Miller; X Luo
Journal:  Am J Transplant       Date:  2010-07-12       Impact factor: 8.086

Review 8.  Harnessing FOXP3+ regulatory T cells for transplantation tolerance.

Authors:  Herman Waldmann; Robert Hilbrands; Duncan Howie; Stephen Cobbold
Journal:  J Clin Invest       Date:  2014-04-01       Impact factor: 14.808

9.  Role of TGF-Beta in the induction of Foxp3 expression and T regulatory cell function.

Authors:  Ethan M Shevach; Todd S Davidson; Eva N Huter; Richard A Dipaolo; John Andersson
Journal:  J Clin Immunol       Date:  2008-09-23       Impact factor: 8.317

10.  Local gene therapy with indoleamine 2,3-dioxygenase protects against development of transplant vasculopathy in chronic kidney transplant dysfunction.

Authors:  D Vavrincova-Yaghi; L E Deelman; H van Goor; M A Seelen; P Vavrinec; I P Kema; P Gomolcak; A Benigni; R H Henning; M Sandovici
Journal:  Gene Ther       Date:  2016-07-25       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.